Company Research Report: Translational Pain Research Program

Company Overview

• Name: Translational Pain Research Program at Brigham and Women’s Hospital

• Mission: The mission of the Translational Pain Research Program is to advance and accelerate the identification of new treatments to bring relief to and improve the lives of patients suffering from acute and chronic pain conditions. Its primary goal is to enhance pain management by determining the mechanisms that cause various types of pain and systematically evaluating new drugs that selectively improve different components of pain conditions.

• Founded: No information is available

• Founders: No information is available

• Key People:

• Christine N. Sang, MD, MPH, FASA - Director and Principal Investigator

• Kerry O'Donnell, BA - Program Coordinator

• Jia Ke, MSc - Lead Research Technician

• Candinho Gomes, BS - Study Coordinator

• Alexis Perry, BS - Study Coordinator

• Lili Sankey, BS - Study Coordinator

• Headquarters: Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, 75 Francis Street, MRB 604, Boston, MA 02115

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: The program is known for its research in pain management, focusing on both acute and chronic pain conditions, including central and peripheral neuropathic pain. It is particularly recognized for evaluating new pharmacological treatments in clinical trials.

Products

• Products Offered: No specific commercial products are mentioned. The primary offering is research and clinical trials.

• High-Level Description:

• The focus is on research and evaluation of novel drugs, especially non-opioid analgesics, which affect different pain mechanisms.

• Key Features:

• Evaluation of new drugs from Phases Ia to IIb clinical trials.

• Use of experimental pain models.

• Matching individual patients with appropriate therapies under evaluation.

Recent Developments

• Recent Developments in the Company:

• Current studies at the Translational Pain Research focus on evaluating different pharmacological treatments, especially non-opioid analgesics.

• New Products Launched: No information is available

• New Features Added to Existing Products: No information is available

• New Partnerships:

• The research is sponsored by various notable entities, which include:

• National Institute of Neurological Diseases and Stroke

• Christopher Reeve Foundation

• Mike Utley Foundation

• Paralyzed Veterans of America

• Lilly Research Laboratories

• Endo Pharmaceuticals, Inc.

• Pfizer, Inc.

• Johnson & Johnson Subsidiaries

• AstraZeneca

• Schwarz Pharma

• Cogentix, Inc.

• Gedeon Richter Ltd.

Contact Information

• Contact Details:

• Phone: 617-525-PAIN (7246)

• Fax: 425-675-5556

• Email: paintrials@partners.org

• Address: Translational Pain Research, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, 75 Francis Street, MRB 604, Boston, MA 02115

This report focuses solely on the information available from the provided data on the Translational Pain Research Program at Brigham and Women's Hospital, highlighting their mission, key personnel, headquarters, and research activities.